Cannabis Moves to Schedule III
On December 18, 2025, President Donald Trump signed a historic executive order directing federal agencies to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act. This landmark decision represents the most consequential shift in U.S. cannabis policy in more than half a century—formally recognizing cannabis’s legitimate medical value at the federal level for the first time.
At Vibe By California, we’re “by the cannabis culture, for the cannabis culture”—and we’re serious about cannabis and good vibes. That means cutting through the noise and giving you the real story: what’s actually changing, what’s staying the same, and why this matters for California cannabis consumers.
Federal Recognition and Key Impacts
Schedule III status formally acknowledges cannabis has “legitimate medical uses” under federal law—ending decades of denial. This recognition opens new pathways for research, allows the FDA to study cannabis for medical purposes, and potentially brings CBD therapies to Medicare patients through a new pilot program.
The Biggest Business Impact: 280E Relief Is Finally Here
One of the most transformative outcomes of Schedule III status is the end of IRS Section 280E for compliant cannabis businesses. Under current law, because cannabis was classified alongside heroin and LSD, licensed dispensaries couldn’t deduct normal business expenses—creating an impossibly punishing tax burden that only helped illicit operators.
What 280E relief could mean for California consumers:
- Better prices — More capacity to compete fairly with illicit operators
- Higher quality — Investment in testing, cultivation, and product innovation
- Improved experience — More resources for staff training and customer education
- Stronger legal market — Less money burned on punitive taxes, more staying in the regulated ecosystem
Cannabis industry leaders have praised the move. According to statements from multiple operators, rescheduling marks a historic step that will accelerate research, reduce stigma, attract new investment, and ease the tax burdens that have held the legal industry back.
Research Access: The U.S. Is Finally Positioned to Lead
For decades, Schedule I classification made legitimate cannabis research nearly impossible. Scientists faced bureaucratic nightmares just to study a plant that millions of Americans already use. Schedule III status removes those barriers and allows the FDA to properly study cannabis for medical purposes.
This matters because the future of cannabis should be built on evidence-based medicine, clearer dosing standards, and precise product innovation—not outdated prohibition-era restrictions. At Vibe, we’ve always believed that regulated cannabis wins when science + compliance + culture move together.
What This Does NOT Mean
Let’s be crystal clear: this is NOT nationwide legalization. Cannabis remains federally controlled, and your day-to-day access still depends entirely on California state law, licensed retailers like Vibe, and full compliance. The executive order directs DEA and DOJ to finalize the rescheduling process—the implementation still needs to work through federal agencies.
What Happens Next: The Process Matters
While the executive order is historic, the president cannot unilaterally reschedule cannabis. The order directs the DOJ and DEA to publish a final rule moving cannabis to Schedule III and to bypass the administrative hearing process that had stalled progress under previous administrations. Key developments to watch:
- DEA Final Rule — Implementation details and official timeline
- SAFER Banking Act — Potential push for cannabis banking access through Congress
- Descheduling Commission — A commission to study full federal descheduling may be announced before summer
- State-Federal Alignment — How California and other legal states integrate with new federal guidance
What This Means for Vibe Customers in California
Here’s the bottom line for California cannabis shoppers:
- Nothing Changes Overnight at Checkout — California rules still govern what’s sold, how it’s tested, and how it’s packaged. Your shopping experience at Vibe remains the same.
- The Legal Market Gets Stronger — If 280E pressure eases, licensed operators like Vibe have more room to compete on price and reinvest into your experience.
- Better Information Coming — Research access can improve the quality of information you receive—especially for wellness-focused and medical consumers.
Public Support for Cannabis Reform
Americans support cannabis reform in growing numbers: 64% of U.S. adults support legal cannabis (Gallup 2025), 24 states have legalized recreational cannabis, and it’s been more than 50 years since cannabis was placed on Schedule I.
Shop California’s Best Cannabis at Vibe
By the cannabis culture, for the cannabis culture. Visit your local Vibe dispensary in Sacramento, Stockton, Redding, Ukiah, Moreno Valley, or Portland.
The Vibe Bottom Line
If Schedule III treatment is implemented, this represents a real inflection point: better research pathways, a more viable regulated market, and fewer outdated penalties on compliant operators—while not flipping a switch to nationwide legalization. That’s the kind of progress we can work with: practical, regulated, and built for the long game.
This article is for informational purposes only and does not constitute legal or financial advice. Cannabis laws vary by jurisdiction. Always purchase from licensed dispensaries and consume responsibly. Must be 21+ to purchase cannabis products in California.
